Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Pulmonary nodule cost-effectiveness of therapy
Introduction
Overview
Overview
Navigational bronchoscopy and computed tomography with fine needle aspiration has been shown to be cost-effective in the initial diagnostic strategies of pulmonary nodules.
Cost-effective Therapy
Cost-effective Therapy
Navigational bronchoscopy and computed tomography with fine needle aspiration diagnostic strategies are most cost-effective compared to either VATS biopsy or 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) scan to diagnose lung cancer in moderate to high-risk pulmonary nodules and resulted in fewer nontherapeutic operations when FDG-PET specificity was < 72%. In regions of the country where specificity is low, FDG-PET scan may not be cost-effective for diagnosis of lung cancer. [1]
References
References
- ↑ Deppen SA, Davis WT, Green EA, Rickman O, Aldrich MC, Fletcher S; et al. (2014). “Cost-effectiveness of initial diagnostic strategies for pulmonary nodules presenting to thoracic surgeons”. Ann Thorac Surg. 98 (4): 1214–22. doi:10.1016/j.athoracsur.2014.05.025. PMC 4186897. PMID 25087933.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Joanna Ekabua, M.D. [2]